{
  "id": "505b0b94506adedb",
  "title": "Cablivi Approved for Pediatric Acquired Thrombotic Thrombocytopenic Purpura",
  "description": "20260106T184500Z",
  "content": "",
  "source": "empr.com",
  "source_url": "https://www.empr.com/news/cablivi-approved-for-pediatric-acquired-thrombotic-thrombocytopenic-purpura/",
  "published_at": "20260106T184500Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.empr.com/news/cablivi-approved-for-pediatric-acquired-thrombotic-thrombocytopenic-purpura/",
    "url_mobile": "",
    "title": "Cablivi Approved for Pediatric Acquired Thrombotic Thrombocytopenic Purpura",
    "seendate": "20260106T184500Z",
    "socialimage": "https://www.empr.com/wp-content/uploads/sites/7/2024/01/MPR_1200x675.png",
    "domain": "empr.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}